| Browse All

China SXT Pharmaceuticals, Inc. (SXTC)

Healthcare | Drug Manufacturers - Specialty & Generic | Taizhou, China | NasdaqCM
2.06 USD +0.05 (2.488%) ⇧ (April 20, 2026, 4 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:34 a.m. EDT

SXTC demonstrates a catastrophic short-term forecast with predicted -50.6% price correction (rating 0: strong sell), driven by negative earnings, declining revenue (-24.5%), and recent equity dilution. The long-term outlook is equally poor (rating 0) due to value-trap fundamentals including -50.3% ROE, negative free cash flow, and a lack of dividend history, making it an unsuitable candidate for buy or hold strategies.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.956249
MSTL1.516429
AutoARIMA1.619329
AutoETS1.673543

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 55%
H-stat 1.13
Ljung-Box p 0.000
Jarque-Bera p 0.002
Excess Kurtosis 0.57
Attribute Value
Sector Healthcare
Debt to Equity Ratio 5.947
Revenue per Share 3.895
Market Cap 1,973,644
Beta 1.75
Website https://www.sxtchina.com

Info Dump

Attribute Value
52 Week Change -0.9933974
Address1 178 Taidong Road North
All Time High 350,250.0
All Time Low 1.25
Ask 2.16
Ask Size 1
Average Daily Volume10 Day 54,160
Average Daily Volume3 Month 273,535
Average Volume 273,535
Average Volume10Days 54,160
Beta 1.754
Bid 1.98
Bid Size 1
Book Value 26.158
City Taizhou
Compensation As Of Epoch Date 1,767,139,200
Country China
Crypto Tradeable 0
Currency USD
Current Price 2.06
Current Ratio 4.368
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 2.07
Day Low 1.95
Debt To Equity 5.947
Display Name China SXT Pharmaceuticals
Ebitda -8,335,278
Ebitda Margins 0.0
Enterprise To Ebitda 2.221
Enterprise To Revenue -12.035
Enterprise Value -18,510,284
Eps Trailing Twelve Months -57.15
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.05344
Fifty Day Average Change 0.006559849
Fifty Day Average Change Percent 0.0031945654
Fifty Two Week Change Percent -99.339745
Fifty Two Week High 1,047.0
Fifty Two Week High Change -1,044.94
Fifty Two Week High Change Percent -0.9980324
Fifty Two Week Low 1.25
Fifty Two Week Low Change 0.80999994
Fifty Two Week Low Change Percent 0.64799994
Fifty Two Week Range 1.25 - 1047.0
Financial Currency USD
First Trade Date Milliseconds 1,546,612,200,000
Float Shares 702,049
Free Cashflow -1,948,357
Full Exchange Name NasdaqCM
Full Time Employees 75
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.21742001
Gross Profits 334,395
Has Pre Post Market Data 1
Held Percent Insiders 0.09237
Held Percent Institutions 0.00074
Implied Shares Outstanding 958,080
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Language en-US
Last Fiscal Year End 1,743,379,200
Last Split Date 1,770,076,800
Last Split Factor 1:150
Long Business Summary China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Long Name China SXT Pharmaceuticals, Inc.
Market us_market
Market Cap 1,973,644
Market State PRE
Max Age 86,400
Message Board Id finmb_545675635
Most Recent Quarter 1,759,190,400
Net Income To Common -8,869,886
Next Fiscal Year End 1,774,915,200
Non Diluted Market Cap 1,973,644
Open 2.03
Operating Cashflow -2,740,720
Operating Margins -10.116859
Payout Ratio 0.0
Phone 86 523 8629 8290
Pre Market Change -0.103299975
Pre Market Change Percent -5.014562
Pre Market Price 1.9567
Pre Market Time 1,776,770,757
Previous Close 2.01
Price Hint 4
Price To Book 0.07875219
Price To Sales Trailing12 Months 1.2832644
Profit Margins 0.0
Quick Ratio 4.038
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.049999952
Regular Market Change Percent 2.4875598
Regular Market Day High 2.07
Regular Market Day Low 1.95
Regular Market Day Range 1.95 - 2.07
Regular Market Open 2.03
Regular Market Previous Close 2.01
Regular Market Price 2.06
Regular Market Time 1,776,715,200
Regular Market Volume 30,233
Return On Assets -0.18267
Return On Equity -0.50299
Revenue Growth -0.245
Revenue Per Share 3.895
Sand P52 Week Change 0.34445214
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 958,077
Shares Percent Shares Out 0.0748
Shares Short 63,863
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 52,570
Short Name China SXT Pharmaceuticals, Inc.
Short Percent Of Float 0.0748
Short Ratio 0.84
Source Interval 15
Symbol SXTC
Total Cash 21,306,964
Total Cash Per Share 27.545
Total Debt 1,203,223
Total Revenue 1,537,987
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -57.15
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 153.54732
Two Hundred Day Average Change -151.48732
Two Hundred Day Average Change Percent -0.98658395
Type Disp Equity
Volume 30,233
Website https://www.sxtchina.com
Zip 225,300